Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-06-07

FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Macleods Pharmaceuticals Limited)

View source ↗

Summary

FDA approved a supplemental application for METFORMIN HYDROCHLORIDE by Macleods Pharmaceuticals Limited (ANDA206955).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METFORMIN HYDROCHLORIDE (Metformin hydrochloride)

Snippet

SUPPL AP for METFORMIN HYDROCHLORIDE (METFORMIN HYDROCHLORIDE)